GE HealthCare CFO Departs as Q2 Revenue Beats, EPS Surprises to Upside
GEHC is trading near its 52-week low of $58.75 (4.0% above the low).
Summary
CFO Jay Saccaro is leaving for a role outside medtech, with controller George Newcomb stepping in as interim. The bigger news: preliminary Q2 revenue rose 5.7% to ~$5.3B, and both reported and adjusted EPS grew year-over-year — a sharp reversal from prior guidance for a low-single-digit decline. Full-year guidance was reaffirmed, suggesting the beat may be timing-related rather than a fundamental upgrade. The stock is trading near its 52-week low, so this positive surprise could spark a relief rally. Complete results on July 29 will clarify the drivers and sustainability.
At the time of this announcement, GEHC was trading at $61.11 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $28.2B. The 52-week trading range was $58.75 to $89.77. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: dpa-AFX.